|
Condensed Consolidated Statements of Operations (Unaudited) (USD $)
|
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
|
Sep. 29, 2012
|
Oct. 01, 2011
|
Sep. 29, 2012
|
Oct. 01, 2011
|
|
| Net revenues: | ||||
| Net commercial product revenues | $ 1,301,000 | $ 470,000 | $ 2,174,000 | $ 3,174,000 |
| Government and other contract revenues | 30,000 | 9,000 | 152,000 | 41,000 |
| Total net revenues | 1,331,000 | 479,000 | 2,326,000 | 3,215,000 |
| Costs and expenses: | ||||
| Cost of commercial product revenues | 1,021,000 | 1,093,000 | 2,943,000 | 4,027,000 |
| Cost of government and other contract revenue | 18,000 | 9,000 | 113,000 | 39,000 |
| Research and development | 1,315,000 | 1,065,000 | 3,790,000 | 4,414,000 |
| Selling, general and administrative | 1,247,000 | 1,658,000 | 4,199,000 | 4,993,000 |
| Total costs and expenses | 3,601,000 | 3,825,000 | 11,045,000 | 13,473,000 |
| Loss from operations | (2,270,000) | (3,346,000) | (8,719,000) | (10,258,000) |
| Other Income and Expense: | ||||
| Other Income | 7,000 | 44,000 | ||
| Interest income | 1,000 | 16,000 | 6,000 | 20,000 |
| Interest expense | 1,000 | (13,000) | ||
| Net loss | $ (2,262,000) | $ (3,329,000) | $ (8,669,000) | $ (10,251,000) |
| Basic and diluted loss per common share | $ (0.06) | $ (0.10) | $ (0.23) | $ (0.33) |
| Weighted average number of common shares outstanding | 39,511,809 | 32,224,901 | 38,331,381 | 31,538,181 |